1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 14 (Search time: 0.006 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: Should the clinical laboratory be testing this agent?Espinel-Ingroff, A.; Arendrup, M.; Pfaller, M.; Bonfietti, L.; Bustamante, B.; Canton, E.; Chryssanthou, E.; Cuenca-Estrella, M.; Dannaoui, E.; Fothergill, A.; Fuller, J.; Gaustad, P.; Gonzalez, G.; Guarro, J.; Lass-Florl, C.; Lockhart, S.; Meis, J.; Moore, C.; Ostrosky-Zeichner, L.; Pelaez, T.; et al.
2015Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations.Aloia, A.; Eyre, N.; Black, S.; Bent, S.; Gaeguta, A.; Guo, Z.; Narayana, S.; Chase, R.; Locarnini, S.; Carr, J.; Howe, J.; Beard, M.
2013Regional resistance surveillance program results for 12 Asia-Pacific nations (2011)Mendes, R.; Mendoza, M.; Banga Singh, K.; Castanheira, M.; Bell, J.; Turnidge, J.; Lin, S.; Jones, R.
2013Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution MethodEspinel-Ingroff, A.; Chowdhary, A.; Gonzalez, G.; Lass-Florl, C.; Martin-Mazuelos, E.; Meis, J.; Pelaez, T.; Pfaller, M.; Turnidge, J.
2016Predictability of phenotype in relation to common β-lactam resistance mechanisms in Escherichia coli and Klebsiella pneumoniaeAgyekum, A.; Fajardo-Lubián, A.; Ai, X.; Ginn, A.; Zong, Z.; Guo, X.; Turnidge, J.; Partridge, S.; Iredell, J.; Ledeboer, N.
2011Cefazolin and enterobacteriaceae: Rationale for revised susceptibility testing breakpointsTurnidge, J.
2011Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high Vancomycin minimum inhibitory concentrationsHolmes, N.; Turnidge, J.; Munckhof, W.; Robinson, J.; Korman, T.; O'Sullivan, M.; Anderson, T.; Roberts, S.; Gao, W.; Christiansen, K.; Coombs, G.; Johnson, P.; Howden, B.
2010In vitro antifungal activities of bis(alkypyridinium)alkane compounds against pathogenic yeasts and moldsChen, S.; Biswas, C.; Bartley, R.; Widmer, F.; Pantarat, N.; Obando, D.; Djordjevic, J.; Ellis, D.; Jolliffe, K.; Sorrell, T.
2012Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and VoriconazoleEspinel-Ingroff, A.; Aller, A.; Canton, E.; Castanon-Olivares, L.; Chowdhary, A.; Cordoba, S.; Cuenca-Estrella, M.; Fothergill, A.; Fuller, J.; Govender, N.; Hagen, F.; Illnait-Zaragozi, M.; Johnson, E.; Kidd, S.; Lass-Florl, C.; Lockhart, S.; Martins, M.; Meis, J.; Melhem, M.; Ostrosky-Zeichner, L.; et al.
2013Vancomycin AUC/MIC ratio and 30-Day mortality in patients with Staphylococcus aureus bacteremiaHolmes, N.; Turnidge, J.; Munckhof, W.; Robinson, J.; Korman, T.; O'Sullivan, M.; Anderson, T.; Roberts, S.; Warren, S.; Gao, W.; Howden, B.; Johnson, P.

Discover